Pregnancy outcome in systemic lupus erythematosus complicated by anti-phospholipid antibodies

Rheumatology

Volumn 48, Issue 3, 2009, Pages 246-249

  Mecacci, F ^a   Bianchi, B ^a   Pieralli, Annalisa ^a   Mangani, B ^a   Moretti, A ^a   Cioni, R ^a   Giorgi, L ^a   Mello, G ^a   Matucci Cerinic, M ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Activity; Anti phospholipid antibodies; Anti phospholipid syndrome; Gestational hypertension; Heparin; Low molecular weight; Pre eclampsia; Pregnancy; Pregnancy outcome; Systemic lupus erythematosus

Indexed keywords

ACETYLSALICYLIC ACID; DALTEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PHOSPHOLIPID ANTIBODY; PREDNISONE;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CONTROLLED STUDY; DESCRIPTIVE RESEARCH; DISEASE ACTIVITY; DRUG DOSE INCREASE; EMBRYO; FEMALE; FETUS; HUMAN; HYPERTENSION; INCIDENCE; LOW DRUG DOSE; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; NEWBORN; OUTCOME ASSESSMENT; PREECLAMPSIA; PREGNANCY OUTCOME; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES;

EID: 61349183314     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ken458     Document Type: Article

References (24)

1. Cutolo M, Matucci-Cerinic M, Lockshin MD, Østensen M. Pregnancy in the rheumatic diseases. Rheumatology 2008;47(Suppl. 3):iIi1.
2. Khamashta, Cruz DID, Hughes GRV. Systemic lupus erythematosus. Lancet 2007;369:587-9.
3. Ware Branch D, Khamashta MA. Antiphospholipid syndromme: Obstetric diagnosis, management, and controversies. Obstet Gynecol 2003;101:1333-44.
4. Ruiz-Irastorza G, Khamashta MA, Hughes GRV. Hughes syndrome crosses boundaries. Autoimmun Rev 2002;1:43-8.
5. Cortes-Henandez J, Ordi-Ros J, Paredes F, Casellas M, Castillo F, Vilardell-Tarres. Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: A prospective study of 103 pregnancies. Rheumatology 2002;41:643-50.
6. Tincani A, Bompane D, Danieli E, Doria A. Pregnancy, lupus and antiphospholipid syndrome. Lupus 2006;15:156-60.
7. Sharer Y, Matalon ST, Blank M, Matsuura E, Shoenfeld Y. Multiple autoantibodies associated with autoimmune reproductive failure. J Assist Reprod Genet 2003;20:53-7.
8. Mascola MA, Repke JT. Obstetric management of the high-risk lupus pregnancy. Rheumatic Dis Clin North Am 1997;23:119-32.
9. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
10. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002;346:752-63.
11. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH; the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: A disease activity index for lupus patients. Arthritis Rheum 1992;35:630-40.
12. Beattie RB, Johnson P. Practical assessment of neonatal nutrition status beyond birth weight: An imperative for the 1990s. Br J Obstet Gynaecol 1994;101:842-6.
13. Lockwood CJ, Weiner S. Assessment of foetal growth. Clin Perinatol 1986;13:3-35.
14. Ruiz-Irastorza G, Lima F, Alves J et al. Increased rate of lupus flare during pregnancy and the puerperium. Br J Rheumatol 1996;35:133-8.
15. Carmona F, Font J, Cervera R, Munoz F, Cararach V, Balasci J. Obstetrical outcome of pregnancy in patients with systemic lupus erythematosus. A study of 60 cases. Eur J Obstet Gynecol 1999;83:137-42.
16. Le Thi Huong D, Wechsler B, Vauthier-Brouzes D et al. Outcome of planned pregnancies in systemic lupus erythematosus: A prospective study on 62 pregnancies. Br J Rheumatol 1997;36:772-7.
17. Petri M. Hopkins Lupus Pregnancy Cente.: 1987-1996. Rheum Dis Clin North Am 1997;23:184-92.
18. Khamashta MA. Systemic lupus erythematosus and pregnancy. Best Pract Res Clin Rheumatol 2006;20:685-94.
19. Asherson RA. New subsets of the antiphospholipid syndrome in 2006: 'PRE-APS' (probable APS) and microangiopathic antiphospholipid syndromes ('MAPS'). Autoimmun Rev 2006;6:76-80.
20. El-Magadmi M, Bodill H, Ahmed Y et al. Systemic lupus erythematosus: An independent risk factor for endothelial dysfunction in women. Circulation 2004;100:399-404.
21. Bertsias G, Ioannidis JPA, Boletis J et al. EULAR recommendations for the management of systemic lupus erythematosus. Report of a task force of the EULAR Standing Committee for international clinical studies including therapeutics. Ann Rheum Dis 2008;67:195-205.
22. Girardi G, Redecha P, Salmon EJ. Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nat Med 2004;10:1222-6.
23. Sergio F, Maria Clara D, Gabrielle F et al. Prophylaxis of recurrent preaclampsia: Low-molecular-weight heparin plus low-dose aspirin versus low-dose aspirin alone. Hypertens Pregnancy 2006;25:115-27.
24. Stephenson MD, Ballem PJ, Tsang P et al. Treatment of antiphospholipid antibody syndrome (APS) in pregnancy: A randomized pilot trial comparing low molecular weight heparin to unfractionated heparin. J Obstet Gynaecol Can 2004;26:729-34.